The acceleration of nanomaterials research has brought about increased demands for rapid analysis of their bioactivity, in a multiparametric fashion, to minimize the gap between potential applications and knowledge of their toxicological properties. The potential of Raman microspectroscopy for the analysis of biological systems with the aid of multivariate analysis techniques has been demonstrated. In this study, an overview of recent efforts towards establishing a 'label-free high content nanotoxicological assessment technique' using Raman microspectroscopy is presented. The current state of the art for cellular toxicity assessment and the potential of Raman microspectroscopy are discussed, and the spectral markers of the cellular toxic responses upon exposure to nanoparticles, changes on the identified spectral markers upon exposure to different nanoparticles, cell death mechanisms, and the effects of nanoparticles on different cell lines are summarized. Moreover, 3D toxicity plots of spectral markers, as a function of time and dose, are introduced as new methodology for toxicological analysis based on the intrinsic properties of the biomolecular changes, such as cytoplasmic RNA aberrations, protein and lipid damage associated with the toxic response. The 3D evolution of the spectral markers are correlated with the results obtained by commonly used cytotoxicity assays, and significant similarities are observed between band intensity and percentage viability obtained by the Alamar Blue assay, as an example. Therefore, the developed 3D plots can be used to identify toxicological properties of a nanomaterial and can potentially be used to predict toxicity, which can provide rapid advances in nanomedicine.
Introduction

Nanotoxicology
The increasing interest in, and accelerated research on, naturally occurring or engineered nanomaterials, due to their possible impacts on society in terms of science and technological advancements, has raised questions regarding their health and environmental impact and led to the development of 'Nanotoxicology' as a new branch of toxicology to guide the safe deployment and suitable production of these novel materials [1] [2] [3] .
Materials of nanoscale dimensions have been identified as possessing extraordinary and sometimes unique physicochemical and optical properties [4] [5] [6] , which make them invaluable for a wide range of fields such as materials science [7] , aerospace [8] , cosmetics [9] , medicine [10] , and the pharmaceutical industry [11] , to improve structures and to contribute to the development of new treatment strategies and early diagnosis of many diseases [12] [13] [14] [15] [16] . On the other hand, these properties have also been observed to facilitate their interaction with biological systems, which necessitates their responsible use and rapid toxicological analysis to predict possible adverse consequences [1, 17] . Health organizations have already established plans to promote on-going research in nanoscience as well as nanotoxicology [18, 19] . The Organization for Economic Cooperation and Development (OECD) has published a list of nanomaterials with high economic interest that require immediate investigation in terms of health and environmental impact [19, 20] . The European Union (EU) has established the 'NanoSafety Cluster', which is a consortium of sponsored projects related to toxicology, exposure assessment, mechanism of interaction, and risk assessment of nanomaterials in order to maximize the synergy among European level projects [21] .
Current approaches for toxicological assessment of nanomaterial toxicity
Most of the strategies that have been proposed for the investigation of nanomaterials include the combinational use of toxicity assays, bio-imaging techniques, chemical and biochemical assays, to obtain information regarding to metabolic activity, membrane integrities, cellular viability, and cell death mechanisms upon exposure. Cytotoxicity assays have been widely employed to determine cellular viability and also cell death rate in vitro. For example, tetrazolium salts, such as MTT (3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide), MTS (3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium), XTT (3-bis-(2-methoxy-4-nitro-5-sulfophenyl)-2H-tetrazolium-5-carboxanilide), and WST-1 (2-(2-methoxy-4-nitrophenyl)-3-(4-nitrophenyl)-5-(2,4-disulfophenyl)-2H-tetrazolium) (soluble versions of MTT) assays, have been used to determine cellular viability based on the energy-state of the cell [22, 23] . The Alamar Blue assay (AB), which provides information regarding to overall cell health and proliferative capacity, has also been widely used for determination of nanoparticle toxicity [23] [24] [25] . The lactate dehydrogenase (LDH) [26] and trypan blue [27] assays have been employed to determine cell membrane integrity and cell death rates. For long-term toxicity, the clonogenic assay has been employed to determine colony forming efficiency and decreased or increased survival [28, 29] . Assays such as mitochondrial membrane potential, cellular protonation, and reactive oxygen species production have been used to elucidate mechanisms of action of nanomaterials in cells. Assays that measure the activation of caspases, release of inflammatory factors, and activation of pro-apoptotic bcl-2 proteins provide further information regarding acute toxic effects of nanomaterials inside the cells. Electron microscopy (EM) and optical microscopy have been used for the visualization of nanomaterials in cells. Confocal microscopy (CLSM) has also been used for the visualization of nanomaterials in cells with the aid of fluorescent labels [30] [31] [32] [33] . High content analysis/screening (HCA/HCS) has opened up new perspectives for toxicological assesment by providing multifaceted information with high sensitivity based on automated imaging of 'phenotypic assay endpoints'. The technique has been used for in vitro toxicity assesment, animal disease models, drug discovery, neurobiology [34, 35] , cell signalling [36] [37] [38] , and observation of biochemical changes [37, 39, 40] .
Chronic and genotoxic effects of the nanomaterials have also been widely studied [41] [42] [43] [44] [45] [46] [47] [48] [49] [50] . The Ames assay has been employed to observe gene mutations in Chinese hamster lung (CHL/IU) cells upon exposure to fullerenes [51] . The combination of Ames test, micronuclei assay, and comet assay have been used to demonstrate the effect of silver nanoparticles on Chinese hamster ovary cells [52] . HPLC and immunohistological techniques were employed to observe DNA base modifications on the basis of measurement of oxidized guanine upon silica nanoparticle exposure of the human adenocarcinoma cell line (A549) [53] . The comet assay has been used to identify single DNA strand breaks [48] . Northern blot analysis and PCR is widely employed to observe changes in gene expression [54, 55] .
Although conventional techniques have provided invaluable information regarding the interaction of nanomaterials with living systems, they remain limited in various aspects, such as the requirement of multiple labels and assays, interference of nanomaterials with the assay dyes [29, 56, 57] , cost, and also time required for the investigation.
Cytotoxicity assays are based on measurement of a biomarker, or so-called 'endpoint', which usually has a fluorescent property and corresponds to a specific change to the state of the entire cell population [58] . Specificity of the 'endpoints' to a single type of toxicological event, within the cascade of events occurring upon toxicant exposure, results in inconsistencies of results obtained from different assays. Moreover, the nanomaterials can interfere with some of these assays. Carbon nanotubes have been shown to interfere with the MTT and LDH assays, resulting in misleading results [29, 56, 57] . For the visualization of the cells, optical microscopy remains incomplete due to its limited spatial resolution. Even though EM provides very detailed information, some nanomaterials do not provide the contrast and are therefore invisible within the cellular environment [28, 59] . CLSM has invaluable advantages for visualization of the nanomaterials within the cell, although the low resolution of fluorescent-based techniques limits its potential. Also, some nanomaterials cannot be functionalized with dyes and the dye can leak into the environment, which reduces the reliability of the results [60, 61] . HCS suffers from the disadvantages of the use of fluorescent dyes and specific'endpoints'. The cost, problems in data management, and lack of common standards are also limits in the use of HCS [39] .
Raman microspectroscopy; towards high content nanotoxicological assessment
Raman spectroscopy
Although the Raman-effect was first demonstrated by Sir C. V. Raman and K. S. Krishnan in 1928 [62] , the developments in high powered light sources such as ion lasers widened the applications of Raman spectroscopy in the late 1960s. The developments in charged coupled detector (CCD) arrays, from the 1980s onwards, added benefits to the high laser source intensities, the significant reductions in acquisition time with multichannel signal detection enabling, and significant improvements achieved in signal to noise ratio [63] . In addition, the development of narrow band laser line rejection filters meant that the huge losses in signal from traditional triple monochomator systems could be overcome with the combination of a filter set and a single spectroscopic grating. Raman spectroscopy, as a vibrational spectroscopic technique, has now become a very powerful technique for the characterization and identification of biomolecules and biomolecular species, attributable to the narrow spectral bandwidths and ease of sample preparation [64] .
The developing technology of Raman spectroscopy and high potential of the technique in different areas, from medicine to industry, has led to the development of variants of the Raman spectroscopy technique itself, such as surface enhanced Raman spectroscopy (SERS) [65] , tip enhanced Raman spectroscopy (TERS) [66] , and coherent anti-Stokes Raman spectroscopy (CARS) [67, 68] . These techniques enable Raman spectroscopy to be more sensitive, to perform molecule specific analysis with enhanced signal.
The applicability of Raman microspectroscopy has been widely shown for the analysis of bodily fluids, tumor tissue margining, and analysis of cells and cellular compartments [69] [70] [71] [72] [73] [74] [75] . Raman microspectroscopy has been employed to visualize cells as well as their subcellular organization [73, 74, 76, 77] . The cellular structures have been identified by combining Raman spectroscopy with immunofluorescence imaging [78] , which enabled label-free imaging of live cells. Raman spectroscopy has been also co-registered with fluorescence microscopy for cellular imaging [79] . The differing biochemical composition of nucleus, nucleolus, and cytoplasm has also been identified in a completely label-free manner, based on intrinsic features of biochemicals [73, 80, 81] . The changes of the spectral signatures upon cell death have been shown by comparing spectral features of dead and live cells [82] . The importance of the use of multivariate analysis techniques such as spectral cross-correlation (SCC) and classical least squares (CLS) analysis to extract information from huge Raman data sets was also shown by Keating et al. [76] . Raman spectral phenotyping with the aid of principal component analysis (PCA) has also been studied by comparison of primary cells with cell line models [83] .
Furthermore, as a label-free vibrational spectroscopic technique, both infrared absorption (IR) and Raman spectroscopy have been employed for the localization of nanomaterials inside the cell [77, [84] [85] [86] . Although IR analysis is challenged by the strong contributions of water in biological samples [87] , Raman microspectroscopy is not affected to the same degree and has attracted attention for the analysis of biological samples [88] . Raman microspectroscopy also provides higher intrinsic spatial resolution for subcellular imaging compared to IR [89] .
The correlation between Raman spectral markers of carbon nanotubes (CNTs) and commonly used cytotoxicity assays has been studied by Knief et al. [90] . The studies of Dorney et al. [73] and Keating et al. [76] have shown the localization of nanoparticles in cells and the use of multivariate analysis techniques to obtain more detailed information regarding to subcellular environment. Confocal Raman microspectroscopy has been employed to study the uptake and localization of surface engineered CNTs, aluminium oxide, and cerium dioxide nanoparticlesat single cell level in HepG2 liver cells [91] . The stress effects of silver nanoparticles as a funtion of applied concentration on human mesenchymal stem cells (hMSCs) has also been studied [92] . Uptake of titania and iron oxide nanoparticles into the nucleus of epithelial cells have been shown using Raman imaging with the aid of multivariate classification [93] .
Although there has been huge effort and on-going research in the use of Raman microspectroscopy to explore the cellular interactions of nanomaterials, the studies have been somewhat fragmented and a systematic study of cell-nanoparticle interaction as a function of dose and time has not as yet been reported.
This study aims to aggregate the results of recent studies [46, 50, 74, 94, 95] using Raman microspectroscopic analysis of nanoparticle exposure of cells in vitro, considering cellnanoparticle localization, spectral marker identification as a function of time and dose, and consistency of the method in different cell lines and for different nanoparticles, with a view towards cohesively assessing its potential as a noninvasive, label-free, and high content nanotoxicological screening technique. For specific details of experimental protocols and data processing, the reader is referred to the publications describing the original studies.
In order to establish a toxicological assessment protocol based on Raman microspectroscopy, a progressive and congregate route is followed, from nanoparticle localization to modeling of 3D plots based on spectral markers of toxicity, which will ultimately allow the prediction of toxicity. Different commercially available nanoparticles are used as models throughout the study. 40 nm nontoxic carboxylmodified polystyrene nanoparticles (PSNPs) are employed to determine nanoparticle localization and trafficking, whereas 100 nm toxic amine-modified polystyrene nanoparticles (PS-NH 2 ) are used to determine spectral markers of the toxicity. Generation 5 PAMAM dendrimers are used as a secondary toxic nanoparticle model for comparison of spectral markers of toxicity. Moreover, the consistency of the spectral markers in different cell lines has been investigated using model cell lines for cancerous and non-cancerous cells. Human adenocarcinoma cells (A549, American Type Culture Collection (ATTC) CCL-185), human lung epidermoid (Calu 1, European Collection of Authenticated Cell Cultures (ECACC) 93120818), and human bronchial epithelium cell line (BEAS-2B, ATCC CRL-9609) were chosen as model cell lines as they mimic one of the primary exposure routes of nanomaterials, which is inhalation.
Nanoparticle uptake and trafficking
Raman microspectroscopy has been employed to determine the localization of non-toxic carboxylated polystyrene nanoparticles inside the cellular transport organelles, including early endosomes, lysosomes, and endoplasmic reticulum, as a function of time following their uptake [74] . Confocal microscopy with different organelle staining was used to determine the localization of nanoparticles from 4 to 24 h. Raman microspectroscopy was used to map the subcellular regions, at determined time points by confocal microscopy, to extract information regarding to nanoparticle localization as nanoparticles are trafficked inside the cell.
Due to the variability of surface properties and size of the nanomaterials, cell-nanomaterial interaction can occur in various ways. However, one of the primary uptake mechanisms of the nanoparticles is known to be endocytosis [96] . Although different mechanisms of endocytosis have been identified [97] , endocytosis can be described as uptake of nanomaterials in membrane-based vesicles. A confocal study showed that the uptake mechanism of the carboxylated PSNPs by endocytosis and PSNPs are observed in early endosomes within 4 h. Then, PSNPs are carried to lysosomes, which act as the digestion/recycling system of the cells (12 h). After 12 h exposure of cells to the PSNPs, they are further trafficked to the endoplasmic reticulum, considered to be the final localization point [74] . The Raman spectroscopic mapping of subcellular regions after 4, 12, and 24 h exposure to the PSNPs provided invaluable information regarding not only nanoparticle localization but also identification of Raman signatures of organelles with the aid of multivariate analysis techniques. Early endosomes, lysosomes, and endoplasmic reticulum are mainly composed of lipids that make them difficult to differentiate from each other. However, the study showed the potential of Raman microspectroscopy to differentiate organelle signatures based completely on their intrinsic biochemical properties in completely label-free manner. The differentiating spectral signatures are best viewed as the PCA loadings of 4, 12, and 24 h nanoparticle exposure data sets obtained from pairwise comparison of particle cluster and environment. Figure 1 shows varying the spectral signatures of endoplasmic reticulum, lysosome, and endosomes after 4, 12, and 24 h carboxy-PSNP exposure. The main differences on the spectral profiles of different organelles are highlighted with grey and some of the spectral markers are provided in Fig. 1 .
Acute toxicity of nanoparticles
Effects of nanoparticles in cytoplasm
While carboxylated and neutral PS nanoparticles are known to be nontoxic, their aminated counterparts are known to show acute toxicity as a result of oxidative stress in the endosomal and lysosomal pathway [46, 73, 74] . In order to observe acute toxicity and corresponding responses, time-and dosedependant Raman spectroscopic markers of cellular toxic events were systematically monitored upon PS-NH 2 and PAMAM exposure to cancerous and non-cancerous cells [46, 50, 94, 95] .
Upon PS-NH 2 exposure, the most dominant spectral marker is observed to be the 'doublet band' at 785 and 810 cm -1 in the cytoplasm, which indicates a change in the cytoplasmic RNA as a result of ROS formation, and the doublet band is observed in particle exposed cells even at low doses (EC 25 ) and short exposure times (after 4 h). The intensity of the band systematically and progressively changed as a function of dose and exposure time [46] . The doublet band was also observed in the biochemical features of Calu 1 cells following PS-NH 2 exposure and progressively changed with extended exposure times [50] . When a second toxic nanoparticle model, PAMAM dendrimers, was introduced to the A549 cells, a similar trend to that for PS-NH 2 was observed for the double peak at 785 and 810 cm -1 , which, together with the results obtained from different cell lines and nanoparticle models, validates the changes in cytoplasmic RNA to be a spectral marker of toxicity [94] . The changes in the doublet band, upon exposure to PS-NH 2 , are followed by concomitant and subsequent changes in the higher end of the fingerprint which provides information about protein (Amide I region) and lipid damage (1229 and 1438 cm -1 ). The band at 1438 cm -1 , which has been identified upon PS-NH 2 exposure, was also identified after exposure to PAMAM dendrimers, and it has been observed to provide information regarding lipotoxicity [46, 50, 94] . Therefore, it can be concluded that Raman spectroscopy identifies signatures of the initiating toxic response and following cellular-dependant events, in real-time single assay and, notably, brings new aspect to determination of nanomaterial toxicity by identifying cytoplasmic RNA as a spectral marker, which is not normally identified by conventional toxicity assays. Moreover, the doublet band can be seen as the first strong spectroscopic response of oxidative stress. Although it does not measure the ROS directly, it provides information about the response, which is a ROS related change in cytoplasmic RNA. The onset of ROS formation upon nanoparticle exposure has been observed to be within 2-6 h [98, 99] , and this initial stage of ROS dies away because of the action of intracellular antioxidants with a similar timescale [98] . In contrast, the doublet band is observed only after 8 h exposure to PS-NH 2 and increases further with exposure time. Figure 2 shows the loadings of PCA obtained from pairwise comparison of particle exposed cells (24 h) and corresponding controls. Positive and negative features of the loadings relate to exposed and unexposed cells, relatively, and [46, 50, 94] the figure summarizes spectral markers of acute toxic response in the cytoplasm, identified by Raman microspectroscopy.
The potential of Raman microspectroscopy as a single label-free technique with multi-parametric information was further analyzed by focusing on the validation of the technique by comparing spectral marker evolution in noncancerous cell lines with cancerous cell lines [50] to build a 'high content' and 'label-free' nanotoxicological assessment protocol. The spectral markers of toxic events such as oxidative stress and lysosomal damage have been identified as a function of time, and the study showed that the identified spectral markers for cellular-dependant events show consistency across multiple cell lines, which allow the identification of mechanism of action of the nanomaterial. The findings from the comparison of presence and progression of spectral markers, especially in low wavenumber region, have also shown the applicability of Raman spectroscopy to identify different cell death pathways in cancerous and noncancerous cell lines (Fig. 3) [50], Positive and negative features of the loadings relate to exposed and unexposed cells, relatively. The study showed the potential of Raman spectroscopy to provide further information regarding the mechanism of action as a single label free assay, without use of multiple labels and assays. Fig. 3 Spectral markers of cell death on cancerous (A) and noncancerous (B) cell lines and cytotoxicity assays, which are found to be related to the changes on these spectral markers. Loadings are offset for clarity. The dotted line represents the zero '0' point for each loading, and intensity scale of 0 ± 0.05 is used for comparison. The figure is reproduced from the study of Efeoglu et al. [50] Effects of nanoparticles in the nucleus and nucleolus Another notable outcome from the study has been determined to be the genotoxicity spectral markers. The spectral features of the nucleus and nucleolus showed significant changes as a function of time and dose upon PAMAM exposure. Nanoparticles such as PAMAM dendrimers are not fluorescent and do not provide contrast for EM studies, which makes cellular interaction studies challenging. Moreover, the small size of these dendrimers (~2-10 nm, depending on dendrimer generation) [100] makes them unsuitable for fluorescent labeling, which significantly changes their size and potentially their toxic properties. However, the use of Raman spectroscopy and systematic changes to the spectral signatures of biochemical composition of the cells can be used to elucidate their interaction with DNA and RNA inside the nucleus. The spectral range from 750 to 830 cm -1 is particularly useful to represent the mechanism of action of small non-fluorescent nanomaterials in nucleus and nucleolus. By comparison of PAMAM/DNA and PAMAM/RNA interactions, possible final localization in the cells has been identified as the nucleolus, which is not possible to observe with other current techniques. Spectral signatures of the post-translational modifications and corresponding biochemical changes, information which normally requires the use of multiple assays, have also been identified.
The high degree of consistency upon exposure to different toxicants indicates a promising future for the use of those spectral markers identified by Raman microspectroscopy in nanotoxicology and nanomedicine. Based on the similar trends for the toxicity of different nanoparticles, the evolution of the spectral markers was further investigated to identify common and/or differing spectral markers of toxicity [95] . The findings of the study showed that although spectral markers of cytoplasmic RNA, lipid and protein damage show consistencies, their evolutions show differences as a result of different response rates. Therefore, and PAMAM-G5 exposure are indicated with blue and red lines, respectively. Data are expressed as % of control mean ± SD. The negative side of the loading represents the spectral features of control, whereas positive side represents the cells exposed to PS-NH 2 and PAMAM-G5. Loadings are offset for clarity. The dotted line represents the zero '0' point for each loading, and intensity scale of 0 ± 0.05 is used for comparison [46, 50, 94, 95] it can be concluded that Raman spectroscopy can give not only multi-parametric information based on intrinsic features of biochemicals upon toxicant exposure but also their response rates. Notably, in this study, especially at extended exposure times, a significantly different evolution of spectral markers has been observed for the two different types of toxic nanoparticles, which can be attributed to different cell death mechanisms. Although the changes were more significant at long exposure times, the different response rates of the bands at early time points also provided information regarding the different cell death mechanisms. Cell death upon toxicant exposure can occur in multiple ways, most notably apoptosis and necrosis. The conventional apoptosis/necrosis assays use colorimetric identification based on cellular uptake of dyes and give information related to whether apoptotic or necrotic cell death has occurred. However, Raman microscopy not only provides information regarding whether the cell is apoptotic or necrotic, but also the biochemical path leading to this differentiation (Fig. 4) .
Adopting the terminology of the adverse outcome pathway methodology [101] , upon exposure to a toxicant, the response begins with a molecular initiating event (MIE) that induces a cascade of consequent events. In the current context, the MIE is identified as the initial oxidative stress caused by the ingestion of the nanoparticles in exosomes and ultimately results in a change in cytoplasmic RNA, manifest as changes in the doublet peak of 785 cm -1 and 810cm -1 . The study of Maher et al. [102] showed that the MIE shows particle dependency and induces cellulardependant events that can include, for example, changes in mitochondrial function, activation of caspases, and release of inflammatory factors. However, conventional and commonly used cytotoxicity assays use specific markers that can be defined as 'endpoints' and identify the toxicity as a function of half-maximal effective dose 'EC 50 '. Therefore, these assays remain limited to provide information regarding to multiple events that occur concomitantly or consecutively inside the cell. Raman microspectroscopy shows signatures of this cascade as (B) After 8 h exposure to EC 25 (red) and 24 h EC 10 μM (blue) PAMAM dendrimers. Positive and negative features of the loadings relate to exposed and control cells, relatively. The areas that show similar responses are indicated with highlights. Loadings are offset for clarity. The dotted line represents the zero '0' point for each loading, and intensity scale of 0 ± 005 is used for comparison [46, 94] presence of spectral markers of initiating toxic event at low doses and short exposure times in low wavenumber region (cytoplasmic RNA, indirect ROS), followed by concomitant changes (protein and lipid damage as a result of cellular toxic events) in high wavenumber region of fingerprint.
3D toxic response to nanoparticles determined by Raman microspectroscopy
A notable finding from the studies based on comparison of the spectral profiles was the 3D dimensional correlation of the spectral markers. The 3D response surface of cytotoxicity has previously been highlighted [102] , whereby similar responses are elicited when cells are exposed to higher concentrations of a toxicant for short exposure time and low concentrations for longer exposure times. This 3D relationship is also evident in the time and dose dependences of the spectral markers identified by Raman microspectroscopy. Figure 5 shows the loadings of PC1 obtained from pairwise comparison of cytoplasm of particle exposed cells with their corresponding controls. The positive features represent the biochemical composition of the particle exposed cells, whereas negative features represent the composition of control cells. As seen in Fig. 5A , the loadings of the PCA from the cytoplasm of PS-NH 2 exposed cells show similar trends when cells are exposed to 10 μM (lethal dose) of PS-NH 2 for 8 h and 2.5 μM (sublethal dose) for 48 h. Moreover, the 3D response effect is observed for PAMAM dendrimers even between sublethal doses and the loadings showed similar features when the cells are exposed to EC 10 for 24 h and EC 25 for 8 h (Fig. 5B) .
The 3D response has also been monitored within the nuclear region (nucleus and nucleolus) for cells exposed to PAMAM dendrimers, as seen in Fig. 6 . The spectral markers of genotoxicity, at 750-830 cm -1 , showed similar Loadings are offset for clarity. The dotted line represents the zero '0' point for each loading, and intensity scale of 0 ± 0.05 is used for comparison [94] patterns when cells are exposed to EC 10 for 24 h and EC 25 for 8 h.
The 3D toxic responses, which are observed based on identified spectral markers of the toxicity can be represented in 3D plots of spectral marker intensities, which can be used for the prediction of toxic events of any nanomaterial by observation of the spectral markers. As an example, the Raman spectral data sets for PAMAM dendrimers as a function of time and dose are used as an input to build 3D plots. The four main spectral markers that have been identified throughout the study, 785, 810, 1003, and 1438 cm -1 , are simultaneously plotted against time point and dose. The band intensities of the identified markers have been observed to change as a function of dose and time, which is manifest as an increase in the positive features, or inversion to negative features, of the loading of the PCA. The increase of the intensity of positive features can be attributed to an increase, accumulation, and/or a conformational change of the biochemical constituent, whereas inversion to the negative features indicates damage and loss of the constituent upon exposure, in both cases compared with unexposed control. Figure 7 shows the representative 3D mesh and contour plot created to show spectral marker intensity distribution of the 785 and 810 cm -1 in the cytoplasm as a function of time and dose of PAMAM G5 exposure. A color scale is provided to show intensity of the spectral marker for contour plots. In the 3D plots based on spectral marker intensities, a range of areas from safe to toxic can be identified and the plots can be further applied to different nanoparticles and pharmaceuticals to identify the range into which they fit. The 785 and 810 cm -1 spectral marker was identified as one of the most significant markers observed throughout the study, showing dramatic and progressive changes as a function of dose and exposure times. The band at 785 cm -1 (nucleic acid) showed a progressive decrease with increasing dose, whereas an increase followed by decrease is observed with extended exposure times (Fig. 7A) . When the intensity of the spectral marker band at 785 cm -1 is correlated with 24 h cellular %viability determined by AB assay as EC 10 , EC 25 , EC 50 , and EC 75 , a significant correlation is observed and the intensity of the marker is reduced with reducing viability. The approximate viability values obtained from EC 50 curve fits after 24 h exposure are presented in Fig. 7B in white text. The origin of the 810 cm -1 band has been identified as changes in cytoplasmic RNA as a result of formation of ROS. The intensity reaches its highest value at~24-48 h, after which a significant loss of the signature of cytoplasmic RNA can be observed (Fig. 7C  and D) .
However, this relation is not observed for the band at 810 cm -1 spectral marker. The different dose/time dependencies of the spectral markers can be related to consecutive cascade of events occurring within the cell upon a toxicant exposure. The band at 786 cm -1 originates from the ring breathing modes of nucleic acid bases (U, T, and C) and also from O-P-O backbone. Therefore, the presence of the band in the features of the loadings can be attributed to nucleic acids, RNA, and/or DNA [82, 103, 104] . On the other hand, the band at 810 cm -1 is known to be more specific to sugar-phosphate diester of RNA [105, 106] . The cytoplasmic RNA significantly becomes affected by oxidative stress and increased ROS levels results repression of translation and accumulation of non-coding RNAs. A concomitant increase in the 785 cm -1 band can also be observed in short exposure times. A secondary increase in 785 cm -1 band, which evolves differently compared with 810 cm -1 band, can be attributed to independent toxic event in the cell.
Notably, time evolution of the ROS dependant cytoplasmic RNA band (810 cm -1 ) show significant differences to the simulation models of Maher et al. [102] (Fig. 8) . When the simulated cytotoxic (A) and spectroscopic data (B) are analyzed, while similar patterns are observed, the evolution occurs over a different timescale, which can be related to the formation of ROS as an initiating toxic event followed by changes in cytoplasmic RNA at later times, as response to ROS formation. However, due to the lack of data in our experimental model, the plots remained limited to show time related pattern in extended exposure times.
The 1003 cm -1 (protein) and 1438 cm -1 (lipotoxicity) spectral markers have also been plotted in the same format and are shown in Fig. 9 . The 3D plots show consistency with the 785 cm -1 spectral marker in terms of cellular viability. After 24 h exposure, with increasing dose, cellular viability is decreased with concomitant decrease in the intensity of the bands. Especially, at longer time points, the graphs remained limited due to lack of data.
Future perspectives
The established 3D plots help to illustrate the potential of Raman microspectroscopy as a 'high content nanotoxicological screening technique', which can be used to determine and predict nanotoxicity based on spectral intensities. Although the plots are created for PAMAM dendrimers, the markers are derived from intrinsic properties of biochemical constituents of the cells that are related to individual cellular events, and the plots can be applied to a wide range o f n a n o m a t e r i a l s a n d p o t e n t i a l l y e v e n t o t h e pharmaceuticals.
Further refinements on the development of the plots can be achieved by the use of multiple time points and doses. With improved sensitivities of Raman microspectrometers, or through CARS and SRS techniques, real-time live cell monitoring can potentially be achieved. Moreover, the use of more sophisticated and quantitative multivariate techniques, such as partial least squares regression (PLSR) and multivariate curve resolution-alternating least squares (MCR-ALS), for analysis of Raman spectral data sets for the identification of spectral marker intensities can enable the establishment of improved 3D plots.
Nanocarrier systems for drug delivery applications have attracted significant attention to achieve targeted delivery of [102] drugs in area of interest and to develop personalized medicine [107] [108] [109] [110] [111] . The identified spectral markers and spectral features of Raman active nanocarriers can be further utilized to track the localization of the nanocarriers within a cell, as well as to monitor responses produced in cells upon release of drug from carriers. Notably, the nanocarriers are localized within the cell, initially in endosomes, and can be subsequently trafficked to lysosomes and, for example, the endoplasmic reticulum, and the local environment of the nanoparticles and therefore the encapsulating vesicle can also be characterized by Raman microspectroscopic mapping [74] . In the case where random points in the cytoplasm or nucleus are recorded, at least at low to moderate doses, little or no contribution of the nanoparticles or their encapsulating environment is observed, and the recorded responses are primarily due to the cellular responses.
Conclusion
The work presented in this study has demonstrated the potential of Raman microspectroscopy as a label-free high content toxicological screening technique that can utilized f or t h e r a pi d a d v an c es i n n an o t o xi co l o g y an d nanomedicine and investigation of a wide range of nanomaterials real-time in a rapid, label-free way. The use of Raman microspectroscopy as a toxicological assessment protocol can provide many advantages over current techniques by using intrinsic features of biomaterials. The technique provides multifaceted data that gives information about localization and trafficking, cellular viability, mechanism of interaction, response rates and cell death mechanism, as well as pathways leading to cell death. Continued development of instrumental technologies, and the emergence of nonlinear Raman techniques, promise real time, live cell monitoring of nanoparticle uptake and cellular response, for which more sophisticated, multivariate analysis and data-mining techniques will be required. 
